Top compounds associated with response to LYZL6


Feature Type Standardized
Nominal ANOVA
mRNA Cyclopamine GDSC1000 pan-cancer AAC 0.086 0.1
mRNA BRD-K49290616 CTRPv2 pan-cancer AAC -0.13 0.1
mRNA PD-0325901 CCLE pan-cancer AAC 0.069 0.1
mRNA Bosutinib FIMM pan-cancer AAC 0.55 0.1
mRNA thapsigargin GDSC1000 pan-cancer AAC 0.057 0.1
mRNA AT-7519 GDSC1000 pan-cancer AAC 0.048 0.1
mRNA JQ-1:MK-0752 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.055 0.1
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.053 0.1
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.057 0.1
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.053 0.1
Download CSV